Keros Therapeutics, Inc. Common Stock

KROS us
$11.62
▲ +0.07 (+0.61%)
Volume: 216,069 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 66
  • 21d momentum +4.5%
  • MA aligned bullish
  • RSI 57
🎯 Pullback 38
  • Near upper Bollinger band
  • +3.2% vs 20MA
💎 Value 58
  • -48% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)57.3
MACD+0.033
MA trendBullish
ATR4.19%
21d mom.+4.5%
63d mom.+5.7%
vs 20MA+3.2%
RVOL(20)1.16×
52w low · 10 52w high · 23
-48.5% from 52-week high
20d support 11 · resistance 12

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$229M
PER—
PBR0.87
PSR15.25
EPS$-4.19
ROE-31.7%
ROA-28.9%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA0.29
week1M3M6M1YYTD
+3.84% +4.50% +5.73% +4.87% -26.22% -37.32%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
6/10
🐻 Bear
6/10

14d momentum +2.65%, daily vol 2.70%. Keros Therapeutics, Inc. Common Stock sits in a mixed regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.